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A muscle stem cell for every muscle:
variability of satellite cell biology
among different muscle groups
Matthew E. Randolph† and Grace K. Pavlath*
Department of Pharmacology, Emory University, Atlanta, GA, USA
The human body contains approximately 640 individual skeletal muscles. Despite the
fact that all of these muscles are composed of striated muscle tissue, the biology of
these muscles and their associated muscle stem cell populations are quite diverse.
Skeletal muscles are affected differentially by various muscular dystrophies (MDs),
such that certain genetic mutations specifically alter muscle function in only a subset
of muscles. Additionally, defective muscle stem cells have been implicated in the
pathology of some MDs. The biology of muscle stem cells varies depending on the
muscles with which they are associated. Here we review the biology of skeletal muscle
stem cell populations of eight different muscle groups. Understanding the biological
variation of skeletal muscles and their resident stem cells could provide valuable
insight into mechanisms underlying the susceptibility of certain muscles to myopathic
disease.
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Introduction
Skeletal muscle is a highly organized tissue that comprises up to 40% of a human’s body mass and is
required for essential functions such as metabolism, locomotion and breathing (Janssen et al., 2000;
MacIntosh et al., 2006). The human body contains approximately 640 unique skeletal muscles,
each having distinct functions in human physiology. Multiple factors contribute to skeletal muscle
diversity including embryologic origin, myogenic regulatory pathways, and functional/metabolic
requirements. Muscle heterogeneity is further underscored by the variable sensitivity of speciﬁc
subsets of skeletal muscles to numerous distinct genetic mutations that give rise to muscular
dystrophies (MD; Hoﬀman et al., 1987; Monaco et al., 1988; Bione et al., 1994; Brais et al., 1998;
Bonne et al., 1999; Nonaka, 1999; Emery, 2002; Robinson et al., 2005; Bonnemann et al., 2014;
Vieira et al., 2014). Adult muscle stem cells, called satellite cells, have been implicated in the
pathology of some MDs (Table 1) and may contribute to the variable muscle sensitivity observed
in some dystrophies.
Skeletal muscles are composed of myoﬁbers, large syncytial cells containing hundreds of post-
mitotic myonuclei. Juxtaposed between the basal lamina and the myoﬁber cell membrane, satellite
cells reside at the periphery of skeletal myoﬁbers (Mauro, 1961). Recent studies have demonstrated
that satellite cells expressing paired box protein 7 (Pax7) are the primary myogenic cell required
for muscle regeneration (Lepper et al., 2011; Murphy et al., 2011; Sambasivan et al., 2011). The
majority of knowledge concerning satellite cell biology arises from studies examining somite-
derived muscles such as the quadriceps, gastrocnemius, tibialis anterior (TA), soleus, extensor
digitorum longus, plantaris, biceps, and deltoid muscles, which collectively represent less than 2%
of all skeletal muscles. Intriguingly, satellite cells present in other muscle groups, including trunk,
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TABLE 1 | Muscular dystrophies (MDs) in which deficits in satellite cell function have been implicated in disease pathology.
Muscular
dystrophy
Affected muscles Mutant
gene(s)
Affected protein(s) Altered SC function Reference
Duchenne shoulder, upper limb,
diaphragm, and calf
DMD Dystrophin Replicative exhaustion;
Proliferation; Postnatal
myofiber hypotrophy
Blau et al., 1983; Webster and Blau,
1990; Sacco et al., 2010; Jiang
et al., 2014; Duddy et al., 2015
Limb girdle:
LGMD1B upper limb, shoulder, LMNA Lamin A/C Differentiation Frock et al., 2006
LGMD2A chest, hip, and upper leg CAPN3 Calpain 3 Proliferation to differentiation
transition
Rosales et al., 2013
LGMD2C SGCG γ -Sarcoglycan Decreased number; Replicative
impairment?
Higuchi et al., 1999
LGMD2D SGCA α-Sarcoglycan
LGMD2E SGCB β-Sarcoglycan
LGMD2F SGCD δ-Sarcoglycan
LGMD2H TRIM32 tripartite motif-containing 32 Replicative senescence Kudryashova et al., 2012;
Mokhonova et al., 2015
LGMD2O POMGNT1 Protein O-mannose
beta-1,2-N-acetylglucos-
aminyltransferase
Proliferation Miyagoe-Suzuki et al., 2009
Emery–Dreifuss:
EGMD2
EGMD3
shoulder, upper limb,
and calf
LMNA Lamin A/C Differentiation Favreau et al., 2004; Frock et al.,
2006
EGMD1 EMD Emerin Proliferation; Differentiation Frock et al., 2006; Meinke et al.,
2015
Facioscapulo-humeral
FSHD1 facial, shoulder, upper
arm, foot, and
pelvic-girdle
Chrom.4q35
D4Z4
contraction
DUX4 Differentiation; Myoblast toxicity Kowaljow et al., 2007; Bosnakovski
et al., 2008a,b
DUX4c Proliferation;
Differentiation
Bosnakovski et al., 2008a; Ansseau
et al., 2009
FSHD region gene 1 Proliferation; Differentiation;
Fusion
Chen et al., 2011; Feeney et al.,
2015
Myotonic dystrophy:
DM1 eyelid, face, neck, lower
arms/legs, diaphragm,
intercostals
DMPK Dystophia myotonic protein
kinase
Decreased satellite cell
numbers
Proliferation
Replicative senescence
Beffy et al., 2010
Thornell et al., 2009
Bigot et al., 2009
DM2 eyelid, face, neck, upper
arms/legs, diaphragm,
intercostals
ZNF9 Zinc finger protein 9 Differentiation;
Replicative senescence
Malatesta et al., 2011; Beaulieu
et al., 2012; Renna et al., 2014
Oculopharyngeal upper eyelid, EOM,
pharynx, tongue, upper
arms/legs
PABPN1 Poly adenosine binding
protein-nuclear one
Proliferation
Differentiation
Périé et al., 2006
Apponi et al., 2010
Congenital MD:
Bethlem
Ullrich
upper and lower
arms/legs, neck, lumbar
paravertebral,
intercostals, thigh,
gluteus maximus
COL6A1
COL6A2
COL6A3
Collagen 6A Self-renewal Urciuolo et al., 2013; Gattazzo et al.,
2014
Rigid spine
syndrome
related to
SEPN1
paravertebral,
intercostals, thigh,
gluteus maximus
SEPN1 Selenoprotein N Decreased satellite cell
numbers; Proliferation;
Exhaustion of satellite cell
pool
Castets et al., 2011
diaphragm, larynx, tongue, extraocular, masseter, and
pharynx, deviate from the canonical biology of their limb
counterparts. Here, we address the muscle-speciﬁc variability
of satellite cell biology and postulate how this variability
could contribute to muscle-speciﬁc sensitivities found
in MDs.
Limb Muscle Satellite Cells: Establishing
the Canon
Skeletal muscles of rodent hindlimbs are commonly used to
study satellite cells as these muscles are easy to identify, dissect,
collect, and manipulate experimentally. The skeletal muscles
Frontiers in Aging Neuroscience | www.frontiersin.org 2 October 2015 | Volume 7 | Article 190
Randolph and Pavlath Muscle-dependent satellite cell variability
FIGURE 1 | Embryonic mesodermal contributions to adult skeletal muscles. (A) Schematic of mesodermal origins in a 3–5 somite stage mouse embryo.
(B) Skeletal muscles of the trunk, limb, diaphgram, and tongue arise from somitic mesoderm. In contrast, the extraocular muscles (EOMs) arise from
prechordal mesoderm and cranial paraxial mesoderm of the first pharyngeal arch; the masseter muscle from the first and second pharyngeal arches of the cranial
paraxial mesoderm, and the pharynx from the third and fourth pharyngeal arches of the caudal paraxial mesoderm. Tongue muscles arise from both somitic and
cranial mesoderm while developing within the niche of the cranial mesenchyme, which is supplied by all four pharyngeal arches.
of the limbs and abdomen arise from somitic mesoderm and
are referred to as hypaxial muscles (Figure 1). They arise
developmentally from the ventrolateral dermomyotome of the
segmented paraxial mesoderm. In vivo and in vitro studies
examining limb muscles provide fundamental insights into the
mechanisms and regulatory pathways involved with skeletal
muscle regeneration, muscle growth, and satellite cell biology.
Muscle regeneration is a robust and complex cellular process
that restores injured muscle to a state that is morphologically
and functionally similar to that of uninjured muscle (Figure 2;
Abmayr and Pavlath, 2012). Regeneration of skeletal muscle
occurs in two distinct phases: a degenerative phase and a
regenerative phase (Rai et al., 2014). The main characteristics
of the degenerative phase involve myoﬁber sarcolemmal damage
or myoﬁber necrosis, followed by an inﬂux of mononucleated
inﬂammatory cells and an increase in ﬁbroblasts (Mathew et al.,
2011; Murphy et al., 2011; Rai et al., 2014). Factors released
from damaged myoﬁbers initiate an inﬂammatory response that
recruits neutrophils, macrophages, and activates ﬁbro/adipogenic
progenitors to facilitate the removal of cellular debris and
regulate muscle repair (McLennan, 1996; Lescaudron et al.,
1999; Joe et al., 2010; Uezumi et al., 2010; Pallafacchina et al.,
2013). The basal lamina remains intact acting as a scaﬀold
for the next phase, muscle regeneration (Schmalbruch, 1976).
Several molecular signals, such as growth factors, chemokines,
and cytokines, are released which activate satellite cells both
locally and systemically within the ﬁrst 24–48 h following injury
(Chang and Rudnicki, 2014; Rodgers et al., 2014). Myoblasts then
terminally diﬀerentiate becoming post-mitotic myocytes, which
then fuse with other myocytes or myoﬁbers to regenerate or
repair damaged myoﬁbers. Thereby, new myonuclei are added
to damaged or nascent myoﬁbers (Abmayr and Pavlath, 2012).
A subset of myogenic cells repopulate the satellite cell niche, thus
maintaining and replenishing the quiescent satellite cell pool for
subsequent rounds of regeneration ( Collins et al., 2005; Shinin
et al., 2006).
The role of satellite cells in postnatal growth has also
been studied in limb muscles. In mice, the ﬁrst 3 weeks of
neonatal growth results in a threefold increase in muscle mass
during which the satellite cell population undergoes a signiﬁcant
reduction from ∼30% of myonuclei per myoﬁber down to
5%, following fusion with neonatal muscles. Parallel increases
in myonuclear numbers and cytoplasmic proteins occur up to
postnatal day 21 (White et al., 2010). After postnatal day 21,
satellite cells enter into a quiescent cellular state under the
regulation of Notch signaling (Fukada et al., 2011), but myoﬁber
size continues to increase without the addition of new myonuclei
(White et al., 2010). Recent satellite cell ablation studies have also
shown that myonuclear addition from satellite cells is dispensable
for hypertrophic growth of limb muscles in the adult (McCarthy
et al., 2011). Furthermore, satellite cells do not appear to be
required for maintenance of most adult limb muscles. A recent
satellite cell ablation study found that loss of >90% of adult limb
satellite cells failed to alter muscle size or myoﬁber type in ﬁve
diﬀerent limb muscles with aging (Fry et al., 2015). However,
myonuclear addition does occur at a basal level in uninjured
postnatal limb muscles and may be required for maintenance of
extensor digitorum longus myoﬁber size with aging (Keefe et al.,
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FIGURE 2 | Myofiber structure and cellular progression of myogenesis.
Myofibers are surrounded by a basal lamina, underneath which lie satellite
cells in close apposition to the myofiber. With injury, satellite cells proliferate
and give rise to myoblasts, which differentiate, migrate, adhere, and fuse with
one another to form multiple myotubes within the basal lamina scaffold.
Myoblasts/myotubes fuse with the stumps of the surviving myofiber and
myotubes also fuse with each other to repair the injured myofiber.
Regenerated myofibers are identifiable by the presence of centrally located
nuclei. Representative hematoxylin and eosin stained muscle cross-sections
from chemically injured murine muscles are provided for each stage of muscle
regeneration to illustrate the differential tissue morphology.
2015). Together, these studies suggest that the initial phase of
postnatal muscle growth occurs with the addition of myonuclei
from satellite cells, but maintenance of most adult limb muscle
size is not dependent on satellite cells.
Regulatory genes involved in satellite cell biology have also
been elucidated from studies of limb muscle. In adult skeletal
muscle, quiescent satellite cells express Pax7, a transcription
factor that speciﬁes the myogenic lineage (Seale et al., 2000).
Once activated, satellite cells exit cellular quiescence, enter
the cell cycle, and begin progression through the myogenic
lineage under the control of myogenic regulatory factors (MRFs),
muscle-speciﬁc transcription factors of the basic-helix-loop-
helix (bHLH) class, including myogenic diﬀerentiation protein
(MyoD), myogenic factor 5 (Myf5), myogenic regulatory factor
4 (Mrf4), and myogenin (Weintraub et al., 1991; Olson and
Klein, 1994; Chang and Rudnicki, 2014). MyoD and Myf5 are
expressed during the proliferative phase and regulate myogenic
diﬀerentiation (Cooper et al., 1999; Valdez et al., 2000), while
Mrf4 and myogenin are expressed upon terminal diﬀerentiation
and exit from the cell cycle (Chang and Rudnicki, 2014).
Increasing evidence suggests that satellite cells within a muscle
are heterogeneous (Motohashi and Asakura, 2014). Satellite cells
containing high levels of Pax7 demonstrate slower proliferation
rates, lower metabolism, and resistance toward diﬀerentiation,
indicating a more “stem-like” phenotype compared to satellite
cells with lower levels of Pax7 (Rocheteau et al., 2012). Various
groups have also discovered distinct satellite cell subpopulations
based on diﬀerential expression of other proteins including α7-
integrin, β1-integrin, c-met, CD34, calcitonin receptor, C-X-C
chemokine receptor type 4 (CXCR4), M-cadherin, Myf5, neural
cell adhesion molecule 1, syndecans 3 and 4, and vascular
cell adhesion molecule 1 (Rosen et al., 1992; Cornelison and
Wold, 1997; Beauchamp et al., 2000; Blanco-Bose et al., 2001;
Cornelison et al., 2001; Tamaki et al., 2002; Sherwood et al.,
2004; Fukada et al., 2007; Ikemoto et al., 2007; Kuang et al.,
2007; Kafadar et al., 2009). While the mechanisms underlying
satellite cell heterogeneity are still being elucidated, growing
evidence suggests that satellite cell biology is also variable in a
muscle-dependent manner, as discussed below.
The ‘Other’ Somite-derived Muscles:
Epaxial, Diaphragm, Internal Larynx, and
Tongue Satellite Cells
Epaxial Satellite Cells
Epaxial skeletal muscles include the deep muscles of the back.
Similar to hypaxial muscle development, epaxial muscles arise
from the dorsomedial dermomyotome of the segmented paraxial
mesoderm (Figure 1; Christ and Ordahl, 1995; Burke and
Nowicki, 2003). While the development of epaxial muscle is well
studied (Munsterberg et al., 1995; Tajbakhsh et al., 1997; Borycki
et al., 1999; Gustafsson et al., 2002; McDermott et al., 2005;
Borello et al., 2006; L’Honore et al., 2010; Sato et al., 2010), the
biological properties of adult epaxial satellite cells remain largely
unknown. Mouse models expressing nLacZ under the control
of the Pax3 promoter showed coexpression of Pax3 and Pax7
is retained in the majority of adult satellite cells of the deep
ventral trunk muscles (Relaix et al., 2006). Pax3 expression was
also maintained in cultured epaxial myoblasts, suggesting that
Pax3 may contribute to both the quiescent and activated states of
epaxial satellite cells (Relaix et al., 2006). How Pax3 contributes
to adult epaxial satellite cell biology and the role of Pax3 in
epaxial muscle regeneration remains to be determined, as well
of other fundamental aspects of epaxial satellite cell biology and
myogenesis.
Diaphragm Satellite Cells
The diaphragm muscle is composed of three distinct domains:
crural muscle, costal muscle, and a central tendonous
domain (Anraku and Shargall, 2009). Recent studies provide
evidence that the muscle components arise from the lateral
dermomyotome of the cervical somites while the central
tendonous connective tissue arises from the pleuroperitoneal
folds of lateral plate origin (Figure 1; Noden et al., 1999;
Mootoosamy and Dietrich, 2002; Pickering and Jones, 2002;
Babiuk et al., 2003; Brown et al., 2005; Merrell et al., 2015).
Postnatally, diaphragmatic satellite cells diﬀer from hypaxial
muscle in that Pax3 expression is maintained along with Pax7
and Myf5 (Relaix et al., 2006; Day et al., 2007; Stuelsatz et al.,
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2012). Recent studies indicate that satellite cell-derivedmyoblasts
of the diaphragm behave diﬀerently than those of the hindlimb
in vitro. Using the Nestin-GFP mouse model (Day et al., 2007)
to identify self-renewal of myoblasts, Stuelsatz et al. (2014)
found higher percentages of GFP+ cells in diaphragm verses
limb muscle cultures. In vitro clonal expansion assays revealed
that diaphragmatic myoblasts proliferated similarly to those of
hindlimb muscles (Chen et al., 2011; Stuelsatz et al., 2012), but
myogenic diﬀerentiation of diaphragm cultures consistently
reached maximum fusion indexes earlier than limb cultures
(Stuelsatz et al., 2014). However, other studies demonstrated that
diaphragmatic satellite cells undergo increased proliferation and
decreased diﬀerentiation in vitro when compared to limb, trunk,
and craniofacial muscles (Ippolito et al., 2012). The discrepancies
in these studies evidence the need for further examination of
diaphragmatic satellite cell biology. In vivo studies also indicate
some interesting biology associated with diaphragmatic satellite
cells. In vivo lineage tracing studies examining the contribution
of diaphragmatic satellite cells to uninjured diaphragm muscles
revealed continued addition of new myonuclei with age, yet
myoﬁber size was not aﬀected with satellite cell ablation (Keefe
et al., 2015). One study in rats suggests that heterogeneity exists
in the response of diaphragmatic satellite cells to the growth
promoting stimuli provided by hemi-diaphragm denervation.
By examining satellite cell numbers associated with various
ﬁber types, this study found that only type IIx/b myoﬁbers of
the compensating non-denervated hemi-diaphragm showed
signiﬁcant increases in satellite cell numbers in both juvenile and
adult mice, while no changes in number were associated with
Type I or IIa myoﬁbers (Kawai et al., 2012). Taken together, our
current understanding of diaphragmatic satellite cell biology is
still rudimentary and warrants further study, both in vivo and in
vitro.
Intrinsic Laryngeal Satellite Cells
The intrinsic muscles of the larynx are critical for respiration,
airway protection and vocalization and include the
thyroarytenoid, posterior cricoarytenoid (PCA), and lateral
cricoarytenoid muscles. The intrinsic laryngeal muscles arise
from the occipital somites during development (Figure 1; Noden
et al., 1999; Noden and Francis-West, 2006). In thyroarytenoid
and PCA muscles, basal levels of myonuclear addition were
discovered using BrdU lineage tracing, suggesting that uninjured
laryngeal muscle contains a subset of proliferating satellite
cells (Goding et al., 2005). In vitro studies also found increased
proliferation rates associated with Erk1/2 phosphorylation
in primary laryngeal muscle cultures compared to hindlimb
cultures (Walz et al., 2008). In response to laryngeal denervation,
laryngeal satellite cell activation and proliferation occurs in
vivo within days following denervation (Kumai et al., 2007)
with myonuclear addition occurring in all intrinsic laryngeal
muscles analyzed (Shinners et al., 2006). Surprisingly, myogenic
cells expressing MyoD and myogenin are still present in
thyroarytenoid muscles 2 years post-denervation in humans,
suggesting a unique prolonged regenerative potential in
laryngeal muscle (Donghui et al., 2010). In spite of this, age-
related decreases in laryngeal satellite cell density and impaired
regeneration of thyroarytenoid muscles occur (Malmgren et al.,
2000; Lee et al., 2012). Together, these studies provide intriguing
insights into intrinsic laryngeal satellite cells, but further studies
are needed to elucidate the molecular and regulatory mechanisms
underlying their distinct biology.
Tongue Satellite Cells
Tongue muscles arise from mixed mesodermal origins. The
intrinsic muscles arise from the ﬁrst occipital somite, while
cranial paraxial mesoderm contributes to the formation of the
exterior tongue muscles (Figure 1; Shuler and Dalrymple, 2001;
Czajkowski et al., 2014). To date, knowledge of adult tongue
muscle satellite cell biology is severely limited. A denervation
study of the tongue muscle using 3H-thymidine to label
proliferating cells revealed increased numbers of 3H-thymidine
labeled myonuclei, which suggests fusion of proliferating satellite
cells to the myoﬁbers (McGeachie and Allbrook, 1978). Tongue-
derived myoblasts have been isolated, cultured and successfully
diﬀerentiated into nascent myotubes in vitro, but the myogenic
characteristics of these cells are yet to be directly studied (Ternaux
and Portalier, 1993; LaFramboise et al., 2003).
Craniofacial Satellite Cells: Extraocular,
Masseter, and Pharyngeal
Extraocular Satellite Cells
Extraocular muscles (EOMs) are responsible for rotation and
movement of the eye and include the superior oblique, inferior
oblique, superior rectus, inferior rectus, lateral rectus, and medial
rectus muscles. EOM and their associated satellite cells diﬀer
from other skeletal muscles in that they arise from the prechordal
and cranial paraxial mesoderm of the ﬁrst pharyngeal arch
during development (Figure 1; Couly et al., 1992; Noden and
Francis-West, 2006). Early studies examining the eﬀects of aging
and dystrophic disease suggested EOM muscles are distinct
from their hindlimb counterparts. Aging studies suggested that
EOMs were preferentially spared with aging (Porter et al.,
1998; Schoser and Pongratz, 2006), while studies examining
EOM involvement in Duchenne, Becker, and some limb girdle
MDs also showed a preferential sparing of these muscles
(Kaminski et al., 1992; Emery, 2002). In addition, satellite cells
of EOM have unique gene expression proﬁles in comparison to
quiescent satellite cells of hindlimb muscles (Porter and Baker,
1996; Pacheco-Pinedo et al., 2009). EOM satellite cells also
demonstrate distinct biological diﬀerences when compared to
hindlimb satellite cells. In several species, EOM satellite cells
chronically proliferate in vivo (McLoon and Wirtschafter, 2002a,
2003; Wirtschafter et al., 2004; Christiansen and McLoon, 2006),
which may in part be due to a speciﬁc highly proliferative
subpopulation (Kallestad et al., 2011). The transcription factor
Pitx2 is expressed in postnatal EOM myogenic precursor cells
that are of a CD34+/Sca1−/CD31−/CD45− lineage, which is
thought to contribute to the proliferative properties of EOM
satellite cells (Hebert et al., 2013). In addition, aged EOM
satellite cells maintain proliferative and self-renewal abilities out
to 24 months of age in vitro (Stuelsatz et al., 2014). Furthermore,
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global and orbital EOM satellite cells contribute new myonuclei
to EOM myoﬁbers in the absence of injury (McLoon and
Wirtschafter, 2002a,b, 2003; Wirtschafter et al., 2004; Keefe et al.,
2015). Together, these studies highlight satellite cell biology that is
distinct from hindlimb satellite cells. Because of their proliferative
and self-renewal propensities, EOM satellite cells have been
proposed to be ideal candidates for use in cell-based therapies
of myopathic disease (McLoon et al., 2007; Kallestad et al., 2011;
Stuelsatz et al., 2014). However, in transplantation experiments
in which EOM satellite cells were injected into the TA muscle of
the hindlimb, EOM satellite cells successfully engrafted into the
novel niche, but lost EOM-speciﬁc phenotypes such as expression
of Myh13 and slow-tonic myosin (Sambasivan et al., 2009). These
data suggested that the phenotypes of EOM satellite cells may
be controlled by the niche. In support of this hypothesis, a
recent study suggested that PW1/peg+ interstitial cells (PICs),
which are present in higher numbers in EOM compared to the
TA, provide a promyogenic environment that contributes to the
resistance of both EOM satellite cells andmyoﬁbers to dystrophic
and age-related disease (Formicola et al., 2014). Together, these
data raise some intriguing questions. What roles do intrinsic and
extrinsic mechanisms have on EOM satellite cell biology? Can
such mechanisms be manipulated to improve the quality of life
for individuals suﬀering from myopathic diseases? Studies are
still needed to further elucidate the mechanisms contributing to
the unique phenotypes of these satellite cells.
Masseter Satellite Cells
Adult masseter satellite cells arise from the ﬁrst and second
pharyngeal arches of the cranial paraxial mesoderm with
contributions from the splanchnic mesoderm and express a
unique transcription proﬁle compared to hindlimb satellite cells
(Figure 1; Kelly et al., 2004; Noden and Francis-West, 2006;
Nathan et al., 2008; Sambasivan et al., 2009). Early in vivo
studies demonstrated an impaired regenerative ability inmasseter
muscles compared to hindlimb muscle that was associated with
a lower number of satellite cells during regeneration (Pavlath
et al., 1998). Masseter satellite cells undergo prolonged periods
of proliferation in vitro with a concurrent delay of diﬀerentiation
onset (Ono et al., 2010), which potentially may contribute to
the impaired regenerative response observed in acute injury to
masseter muscle. In contrast, masseter satellite cells increase
in number per myoﬁber with age while their proliferative
capabilities decline ex vivo (Ono et al., 2010). What molecular
pathways are involved with the age-associated increase in satellite
cell numbers in masseter muscles verses the decrease in satellite
cell numbers in other skeletal muscles? Little is known regarding
the underlying molecular mechanisms driving the phenotypes of
masseter satellite cells.
Pharyngeal Satellite Cells
Swallowing depends on the synchronous contraction of seven
major muscles lining the nasal, oral, and laryngeal pharynxes
to ensure propulsion of food and liquid from the oral
cavity into the esophagus (Donner et al., 1985; Rubesin
et al., 1987; Ekberg et al., 2009). Pharyngeal muscles arise
from the cranial paraxial mesoderm of the third and fourth
pharyngeal arches with contributions from splanchnic mesoderm
(Figure 1; Kelly et al., 2004; Noden and Francis-West,
2006; Nathan et al., 2008). Pharyngeal muscles include the
stylopharyngeus, palatopharyngeus, salpingopharyngeus, and the
superior, middle, and inferior pharyngeal constrictor muscles
(Dutta and Basmajian, 1960; Himmelreich, 1973; Donner
et al., 1985; Rubesin et al., 1987; Ekberg et al., 2009). The
inferior pharyngeal constrictor can be subdivided into the
cricopharyngeus and the thyropharyngeus muscles (Donner
et al., 1985; Rubesin et al., 1987; Ekberg et al., 2009). Recent in vivo
and in vitro studies indicate that pharyngeal satellite cells have
unique biological characteristics compared to hindlimb satellite
cells. Pharyngeal muscles contain increased numbers of activated
and proliferating satellite cells and contribute new myonuclei to
pharyngeal myoﬁbers in the absence of induced injury (Randolph
et al., 2015). Additionally, in vitro clonal assays suggest a
highly proliferative subpopulation of pharyngeal satellite cells
could be contributing to the proliferative phenotype (Randolph
et al., 2015). In vivo ablation studies indicated that satellite
cells were required to maintain myonuclear numbers in certain
pharyngeal muscles under basal conditions, suggesting that
pharyngeal muscles undergo myonuclear turnover and require
myonuclear addition from ongoing satellite cell myogenesis
(Randolph et al., 2015). Could pathologic mutations enhance
myonuclear turnover in pharyngeal muscles to such an extent
that pharyngeal satellite cells could no longer adequately supply
enough myonuclei to maintain homeostasis? Do disease-causing
mutations impair the basal myogenic phenotype of pharyngeal
satellite cells, potentially contributing to the pathological
sensitivity of pharyngeal muscles observed in some MDs? These
questions and many more remain to be addressed. However,
several studies have examined pharyngeal satellite cell biology in
the context of oculopharyngeal muscular dystrophy and will be
discussed below.
Could Variable Satellite Cell Biology
Contribute to the Differential
Susceptibility of Certain Muscles to
Dystrophic Mutations?
Muscular dystrophies are a group of degenerativemuscle diseases
due to mutations in proteins ranging in function such as
sarcolemmal structure (Hoﬀman et al., 1987), nuclear envelope
structure (Bione et al., 1994; Bonne et al., 1999; Mittelbronn
et al., 2008), post-translational glycosylation (Bonnemann et al.,
2014), and RNA binding (Brais et al., 1998; Kühn et al.,
2009). Many mutations have been characterized in both skeletal
muscle-speciﬁc and ubiquitously expressed genes, yet both
manifest in muscular pathology. Intriguingly, each dystrophy
aﬀects a speciﬁc subset of skeletal muscles within the human
body (Emery, 2002), suggesting that biological diﬀerences exist
between individual muscles that predispose them to speciﬁc
pathological etiologies.
Satellite cells have been implicated in the pathology of some
MDs and may contribute to the variable muscle sensitivity
observed in some dystrophies through several mechanisms
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(Table 1). For example, in response to chronic myoﬁber
degeneration, satellite cells are subjected to multiple rounds of
regeneration, which can “exhaust” the regenerative abilities of
the satellite cell population over time (Webster and Blau, 1990;
Decary et al., 2000; Morgan and Zammit, 2010; Sacco et al.,
2010). Additionally, satellite cell impairment may occur early
in the disease process if satellite cells express the mutant genes.
Below we discuss the functional deﬁcits in satellite cells observed
in Duchenne MD (Blau et al., 1983; Webster and Blau, 1990;
Sacco et al., 2010), Emery–Dreifuss MD (Favreau et al., 2004;
Frock et al., 2006), facioscapulohumeral MD (Winokur et al.,
2003; Barro et al., 2010), myotonic dystrophy (Furling et al., 2001;
Thornell et al., 2009), oculopharyngeal MD (Périé et al., 2006),
and some congenital MDs as well (Castets et al., 2011; Urciuolo
et al., 2013).
Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is an early onset
childhood X-linked disease associated with the absence of
dystrophin (Hoﬀman et al., 1987), a sarcolemma-associated
cytoplasmic protein critical for maintaining sarcolemmal
integrity of myoﬁbers (Durbeej and Campbell, 2002). Minimal
levels of mechanical stress are needed to impair sarcolemmal
integrity in the absence of dystrophin, resulting in recurrent
rounds of myoﬁber damage and repair (Petrof et al., 1993).
Patients suﬀering from DMD experience progressive loss of
muscle function, eventually leading to death before the age
of 30. The main skeletal muscles aﬀected in DMD are found
in the shoulder, upper limbs, hips, thighs, and calves (Emery,
2002). Life-threatening symptoms for many patients involve
cardiac and respiratory failure from impairment of the heart and
diaphragm muscles, respectively (Nigro et al., 1990; Stedman
et al., 1991). Of note, craniofacial muscles, such as the extraocular
and internal laryngeal muscles, are mostly spared in DMD with
the exception of pharyngeal muscles in advanced stages of the
disease (Kaminski et al., 1992; Emery, 2002; Marques et al., 2007;
Shinonaga et al., 2008). The mechanism of resistance of EOM to
dystrophic changes was recently addressed in irradiation studies
using mdx:utrophin heterozygous mice. EOMs of these mice
failed to develop dystrophic phenotypes even after receiving
18 Gy gamma irradiation. This resistance to dystrophic change
was attributed to the presence of multiple EOM myogenic
precursor populations that prevented loss of myoﬁber size,
suggesting that the proliferative satellite cell populations of EOM
play a role in the muscle sparing of EOM in many dystrophies
(McDonald et al., 2014). Satellite cell abnormalities are noted in
dystrophin-deﬁcient hindlimb muscles of both mice and humans
at early stages of disease. In mouse hindlimb muscles, impaired
satellite cell attachment to mdx myoﬁbers may contribute to the
pre-myonecrosis myoﬁber hypotrophy found in early postnatal
disease (Duddy et al., 2015). Furthermore, premature cell
senescence is observed in cultured myoblasts isolated from limb
muscles of DMD patients as early as 2 years of age, the age of
typical clinical onset (Blau et al., 1983; Webster and Blau, 1990)
attributed to both deﬁciencies in Notch signaling and telomeric
shortening following repeated regenerative cycles (Mouly et al.,
2005; Sacco et al., 2010; Jiang et al., 2014).
Limb-Girdle Muscular Dystrophy
Limb-girdle muscular dystrophies (LGMD) are associated
with mutations of more than 20 diﬀerent genes in both
muscle-speciﬁc and ubiquitously expressed genes with a range
of molecular functions (Vieira et al., 2014). These include
sarcomere proteins (titin), sarcolemmal proteins (sarcoglycan),
glycosyltransferases (fukutin), nuclear envelope proteins (lamin
A/C), and RNA-processing proteins (HNRPDL), to name a
few. Intriguingly, despite the vast etiological variation, all
mutations elicit dystrophic changes in muscles of the upper
limb, shoulder, chest, hip, and upper leg (Broglio et al., 2010;
Mitsuhashi and Kang, 2012). Satellite cell involvement has
been implicated in some LGMDs. Biopsies from LGMD2A
patients demonstrated a decrease in miR-1 and miR206,
microRNAs involved in facilitating satellite cell diﬀerentiation
that correlated with an increased Pax7+ population. Despite
the increased Pax7+ population, regeneration was impaired
and ﬁbrosis elevated, suggesting an impairment of satellite
cell transition from proliferation to diﬀerentiation could be
contributing to the pathology of LGMD2A (Rosales et al., 2013).
In contrast, decreased satellite cell numbers were reported in
patients with α-, β-, or γ-sarcoglycan mutations (LGMD2D,
2E, and 2C, respectively) when compared to Becker muscular
dystrophy patient samples (Higuchi et al., 1999). Additionally,
murine POMGnT1-null myoblasts (representative of LGMD2O)
demonstrated impaired proliferation in vitro (Yoshida et al.,
2001; Miyagoe-Suzuki et al., 2009). In a mouse model for
LGMD2H, knockout of E3 ubiquitin ligase tripartite motif-
containing 32 (TRIM32) resulted in satellite cell senescence both
in vitro and in vivo (Kudryashova et al., 2012; Mokhonova
et al., 2015). Interestingly, pharmacologic induction of follistatin
expression in satellite cells using the deacetylase inhibitor,
trichostatin A, has proved beneﬁcial in restoring myoﬁber size
in α-sarcoglycan-deﬁcient LGMD in vivo (Minetti et al., 2006).
Of note, in vitro treatment of α-sarcoglycan-deﬁcient murine
satellite cells with trichostatin A resulted in hypernucleated
myotubes, suggesting a pharmacologic enhancement of myoblast
diﬀerentiation/fusion (Minetti et al., 2006). It remains to be seen
if other pharmacolgic approaches that alter satellite cell function
might also beneﬁt LGMD patients with other mutations.
Emery–Dreifuss Muscular Dystrophy
Emery–Dreifuss muscular dystrophy results in progressive
weakness of the shoulder, upper limb, and calf muscles of
patients. The most common forms of this dystrophy are caused
by mutations in the ubiquitously expressed nuclear envelope
proteins emerin, lamin A, or lamin C (Helbling-Leclerc et al.,
2002). Why skeletal and cardiac muscles are preferentially
aﬀected in this disease, is still unclear. Patients with Emery–
Dreifuss MD can have severe cardiac pathology occurring as early
as 30 years of age (Vohanka et al., 2001; Emery, 2002; Broglio
et al., 2010). In vitro studies using primary muscle cultures
from Lmna−/− knockout mice, overexpression of mutant lamin
AR453W, or RNAi knockdown of emerin demonstrated defects
in myoblast diﬀerentiation (Favreau et al., 2004; Frock et al.,
2006). In a recent study, in vitro culture of patient-derived
myoblasts lacking emerin demonstrated enhanced proliferation
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with spontaneous diﬀerentiation, compared to control myoblasts,
thus suggesting that satellite cell impairment could play a role in
Emery–Dreifuss MD (Meinke et al., 2015).
Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral muscular dystrophy (FSHD) is named for
the muscles mainly aﬀected in the disease, facial, shoulder, and
upper arm muscles, but foot and pelvic-girdle muscles can also
be aﬀected (Tawil and Van Der Maarel, 2006). Of the dystrophies
aﬀecting craniofacial muscles, FSHD carries the best prognosis
for long-term survival, as it is a slowly progressive disease that
rarely aﬀects the heart or the ability to breathe (Tawil and Van
Der Maarel, 2006). The causative deletion for FSHD type 1
(FSHD1) occurs in the subtelomeric region of chromosome 4,
which can induce the expression of genes such as FSHD region
gene 1 (FGR1), FGR2, ANT1, DUX4, and DUX4c (Gabellini et al.,
2002; Dixit et al., 2007; Ansseau et al., 2009; Bodega et al.,
2009; Snider et al., 2010). The pathogenic contributions of these
genes to FSHD are still being dissected. However, evidence for
satellite cell involvement in FSHD1 is growing. DUX4 expression
in cultured myoblasts inhibited myogenic diﬀerentiation by
repression of Myf5 and MyoD (Bosnakovski et al., 2008a,b,
2009), while overexpression of DUX4 was toxic to myoblasts
in vitro (Kowaljow et al., 2007). In contrast, overexpression
of DUX4c stimulated myoblast proliferation but inhibited
diﬀerentiation in vitro (Bosnakovski et al., 2008a; Ansseau et al.,
2009). Additionally, FGR1 overexpression impaired myoblast
proliferation as well as myoblast fusion (Chen et al., 2011;
Feeney et al., 2015). Primary myoblasts collected from aﬀected
thigh muscles of a transgenic mouse overexpressing FGR1
produced smaller clonal colonies than myoblasts derived from
the unaﬀected diaphragm muscle (Chen et al., 2011). Taken
together, these results indicate that satellite cells could play a
direct role in FSHD1 pathology. The mechanism(s) underlying
the muscle speciﬁcity of these altered myogenic phenotypes
remains to be determined.
Myotonic Dystrophy
Myotonic dystrophy (DM) is a complex, multisystemic group
of dystrophies that genetically arise from untranslated repeat
nucleotide expansions of two separate genes, dystophia myotonic
protein kinase (DMPK) and zinc finger protein 9 (ZNF9) (Day
and Ranum, 2005). A (CTG)80−4000 repeat in the 3′ untranslated
region of DMPK is present in patients with myotonic dystrophy
type 1 (DM1). The expanded regions of DMPK transcripts
result in altered RNA biogenesis and processing of multiple
transcripts, in part, by the sequestration of the splicing factor
muscle blind (MBNL1) and stabilization of CUG-binding protein
1 (CUGBP1; Mastroyiannopoulos et al., 2010). In myotonic
dystrophy type 2 (DM2), up to 75–11,000 repeat expansions of
(TG)n(TCTG)n(CCTG)n reside in intron 1 of ZNF9 (Day and
Ranum, 2005), dysregulating alternative slicing as well as protein
production by sequestration of the 20S proteasome (Salisbury
et al., 2009). While DM1 and DM2 result from distinct genetic
mutations, the biological consequences are similar as myotonia,
muscular dystrophy, muscle pain, cataracts, cardiac arrhythmias,
insulin insensitivity, and diabetes, hypogammaglobulinemia, and
testicular failure occur in both (Schoser and Timchenko, 2010).
DM aﬀects muscles of the eyelid, face, neck, lower arms, and
legs, diaphragm, and intercostal muscles (Batten and Gibb,
1909; Zifko et al., 1996). However, DM1 is associated with
muscle weakness and atrophy in the lower limb muscles, while
in DM2 the disease is more predominant in the upper limbs
(Tieleman et al., 2012). Life-threatening conditions involving
cardiac disease, respiratory failure, and diﬃculties in swallowing
can occur (Zifko et al., 1996; Tieleman et al., 2009, 2012). Satellite
cell number, proliferation and diﬀerentiation are diﬀerentially
altered in DM1 patients. Decreased satellite cell numbers may
result from induced autophagic processes in DM1 myoblasts
(Beﬀy et al., 2010). Cultured myoblasts, obtained from aﬀected
lower limb muscles, proliferated less compared to unaﬀected
upper limb muscle cultures derived from the same patients
(Thornell et al., 2009). Enhanced expression of prostaglandin
E2 by DM1 myoblasts inhibited diﬀerentiation and fusion in
an autocrine manner (Beaulieu et al., 2012). Additionally, the
p16-pathway induced premature senescence in DM1 myoblasts
(Bigot et al., 2009). Satellite cells have also been implicated in
DM2 pathology. For example, satellite cells underwent premature
senescence in DM2 patients, but in a non-p16 dependent manner
through a telomere-driven pathway (Malatesta et al., 2011; Renna
et al., 2014). Impairment of satellite cells could be a major
pathologic determinant in myotonic dystrophies.
Oculopharyngeal Muscular Dystrophy
Oculopharyngeal muscular dystrophy (OPMD) is an autosomal
dominant disease, which typically aﬀects people older than
50 years of age (Abu-Baker and Rouleau, 2007; Messaed and
Rouleau, 2009). An aberrant expansion of alanines in the
N-terminus of poly adenosine binding protein nuclear one
(PABPN1) is the underlying cause of this presently incurable
disease (Brais et al., 1998; Abu-Baker and Rouleau, 2007; Messaed
and Rouleau, 2009). PABPN1 is a ubiquitously expressed protein
that plays key roles in RNA biogenesis (Banerjee et al., 2013).
The endogenous protein contains a 10-alanine repeat at its
N-terminus, but expansions resulting in 12–18 alanines are
reported in OPMD patients (Brais et al., 1998; Abu-Baker
and Rouleau, 2007; Messaed and Rouleau, 2009; Jouan et al.,
2014). Muscle weakness and dystrophy occur preferentially
in craniofacial skeletal muscles including the upper eye-lid,
pharynx, EOMs, and tongue with weakness in upper limb
muscles developing later in the disease (Emery, 2002; Abu-Baker
and Rouleau, 2007; Messaed and Rouleau, 2009).
The major life-threatening diﬃculty for OPMD patients is
the resultant dysphagia, or impairments in swallowing (Périé
et al., 2006). Pharyngeal muscles of the nasal, oral, and laryngeal
pharynxes are essential components of the swallow reﬂex (Miller,
2002; Ertekin and Aydogdu, 2003; Miller, 2008), which prevents
aspiration of food and water into the trachea and lungs and
the formation of life-threatening pneumonia (Martin et al.,
1994; Prasse and Kikano, 2009). Of note, decreased proliferation
of pharyngeal satellite cells isolated from OPMD patients was
observed in vitro (Périé et al., 2006). In transgenic mice that
overexpress wild-type PABPN1 speciﬁcally in skeletal muscle,
increased numbers of myoﬁbers with central nuclei suggested
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a positive eﬀect of wild-type PABPN1 on satellite cell fusion in
vivo (Randolph et al., 2014). Together, the above studies suggest
that PABPN1 plays a critical role in pharyngeal satellite cell
myogenesis and mutations in this protein may contribute to
satellite cell impairment in OPMD patients.
Results from recent clinical trials provide preliminary
evidence for the use of satellite cell transplantation as a
therapeutic treatment for dysphagic OPMD patients. Phase I/IIa
clinical trials were performed with dysphagic OPMD patients
in which myoblasts obtained from unaﬀected skeletal muscles
were ampliﬁed in culture and transplanted into cricopharyngeal
muscles following surgical treatment of the cricopharyngeal
muscle. Patients receiving injections of larger numbers of
myoblasts into the cricopharyngeal area demonstrated signiﬁcant
improvement in swallowing over a 2-years period (Perie et al.,
2014), thus providing experimental support for the use of satellite
cell-based therapies for OPMD patients.
Congenital Muscular Dystrophies
Congenital muscular dystrophies (CMD) represent a large group
of congenital onset muscle diseases. While this group of muscle
diseases has been widely studied, satellite cell involvement has
only been implicated in the pathology of two forms to date:
collagen VI-related myopathies (COL6-RD) and selenoprotein
N-related myopathies (SEPN1-RM). COL6-RD include Ullrich
MD and Bethlem myopathy and arise from mutations in
COL6A1, COL6A2, or COL6A3 (Bonnemann et al., 2014).
Muscle weakness occurs in distal limb, neck ﬂexor muscles,
lumbar, intercostals, and diaphragm, as well as proximal limb
muscles such as the quadriceps, biceps and triceps (Haq et al.,
1999; Camacho Vanegas et al., 2001; Quijano-Roy et al., 2012).
When human biopsy samples were examined for changes in
Pax7+ satellite cell numbers in normal verses Ullrich MD, no
changes were observed (Paco et al., 2012). However, in Col6a1
knockout mice, satellite cell self-renewal was impaired following
multiple bouts of induced injury while satellite cell numbers were
maintained in Col6a1−/− mice when treated with cyclosporin A
(Urciuolo et al., 2013; Gattazzo et al., 2014).Whether these results
are recapitulated in satellite cells from Ullrich MD patients has
yet to be determined. Rigid spine syndrome related to SEPN1 is
a CMD within the SEPN1-related myopathies. Aﬀected muscles
include the thigh, gluteus maximus, paravertebral, intercostal,
and sternocleidomastoid muscles (Quijano-Roy et al., 2012).
Studies examining satellite cells in Sepn1−/− mice revealed
decreased satellite cell numbers, impaired self-renewal, enhanced
satellite cell proliferation, and exhaustion of the satellite cell pool
following one round of regeneration (Castets et al., 2011). These
studies suggest a potential role for satellite cells in the pathology
of some CMDs. Further studies are needed to determine if
satellite cells would be beneﬁcial therapeutic targets for CMD
patients.
Summary
Skeletal muscles are a highly diverse and dynamic group
of tissues. As discussed, many factors contribute to skeletal
muscle diversity including embryologic origin, gene expression,
and functional/metabolic requirements. Such diversity likely
contributes to the pathologic sensitivities of diﬀerent skeletal
muscles to aging and disease. Unfortunately, little is known
about the eﬀects of age or disease on non-limb muscles as
a whole or what factors predispose them to the eﬀects of
pathologic conditions. Additionally, satellite cells could serve
as pathologic determinants in some dystrophies; however, our
knowledge of non-limb satellite cells and their role in muscle
biology is severely lacking. Recognizing and elucidating the
distinct diﬀerences in satellite cell biology between diﬀerent
skeletal muscles could be the key to unraveling the conundrum
of muscle speciﬁcity between the various MDs. This review
highlights the potential beneﬁt of exploring satellite cell
biology of non-limb skeletal muscles for the development
of novel therapeutic approaches for patients suﬀering from
MDs.
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